This is combination formulation, which means it is a tablet formulated with two active pharmaceutical ingredients or drugs. This preparation consists of two active pharmaceutical ingredients or drugs Aceclofenac 100mg and Drotaverine 80mg as per standard solid dosage form. This dose form of two active drug or drugs in a combination tablet is developed through formulation development and those two drugs/drugs may be compatible with each other.
It is formulated with pharmaceutical raw materials and excipients with the appropriate number of inclusions, ensuring the required physical and chemical qualities of the formulation. Manufacturing is carried out at several stages: dispensing, blending, granulation, lubricating, compression, quality control, and packaging.
6. Combination-tablets production Between the active ingredients of a combination-tablet, uniformity is another major concern. By using a well-regulated manufacturing process, this can be achieved.
The active pharmaceutical ingredients are Aceclofenac 100mg and Drotaverine 80mg. Each of the active ingredients has different physical and chemical properties and they are taken into account when developing the formulation.
In the process of designing the formulation, factors such as flow, size, solubility, stability, compatibility, and compression attributes are all considered by pharmaceutical chemists. Such factors can help identify appropriate excipients and manufacturing methods.
The excipients chosen for the formulation may help in powder flow, granulation, blending, tablet making, physical stability, as well as other properties of the product. Ensuring active ingredients are uniformly distributed in the formulation is critical for content uniformity.
Formulation during product development In the formulation, some parameters will be optimized to develop a reproducible manufacturing process. The formulation should result in tablets with uniform attributes between production batches.
Manufacturing Process of Aceclofenac 100mg + Drotaverine 80mg Tablets Aceclofenac 100mg + Drotaverine 80mg Tablets are manufactured with the help of the controlled pharmaceutical production methods and systematic quality-control process. The process usually begins with the purchase and testing of active pharmaceutical components and excipients.
Approved raw materials are correctly weighed and processed, as per validated or specified manufacturing procedure. The manufacturing process consists of sifting, blending, granulation, drying, lubricating, compressing, and inspecting (based on the technology).
In-process quality control can include: in process controls to check the blend, moisture content, tablet weight, hardness, thickness and visual appearance. These controls can be instituted to have consistent production.
Finished-product testing can involve appearance, average weight, weight variation, hardness, friability, disintegration, assay and content uniformity in the specification. 4 Any testing of the analytical methods for combination formulations is especially relevant in the case of the defined concentration of Aceclofenac and Drotaverine.
Additional evidence of a systematic pharmaceutical quality-management system is provided by batch records, laboratory reports, documentation of equipment, and traceability procedures.
Combination tablets should be developed with a focus on physical and chemical compatibility of the constituent ingredients. Aceclofenac 100mg + Drotaverine 80mg Tablets are manufactured keeping in mind the specific properties of the individual ingredients along with their response in the final formulation.
Powders and particles flow and interact, moisture levels can be high or low, compression properties of the powders, hardness, friability and disintegration times all are parameters which affect the finished tablet. Formulation development may require experimentation to arrive at the optimum formulation of excipients and process.
Equality of the finished tablet is another concern, as there are two API's in the final preparation. Uniform mixing and handling are expected to aid the uniform distribution of the API's across a batch.
The stability assessment may be included in the development phase as well. These stability studies enable the manufacturers to evaluate the physical and chemical properties of the formulation for specified storage conditions and develop suitable specifications for the product.
For a fully developed tablet formulation a balance of excipients, optimized process parameters, compression, and analytical evaluation are all required.
Packaging The packaging of Aceclofenac 100mg + Drotaverine 80mg Tablets preserves its quality and identity. Packaging is chosen according to the nature of the formulation and the established pharmaceutical packaging.
Appropriate primary packaging can help to protect the tablets against relevant environmental influences. Secondary packaging can be provided for enhanced protection and marking for handling.
The product label typically contains information like the formulation name, formulation components, strength, batch number, manufacturing details, expiry details, manufacturer details, and other regulatory information.
It also helps in presenting pharmaceutical brands Packaging is yet another factor that does contribute to providing a professional edge for pharmaceutical brands. Having it is easier for pharmaceutical brands to develop a brand image with packaging in place as there are similarities in product packaging to brand …
Standardized packaging and labeling system: For pharmaceutical companies with a range of multiple formulations, a standardized packaging and labeling system makes Identifying the products easier, yet still looks professional.
Aceclofenac 100mg + Drotaverine 80mg Tablets can be added in diversified pharma portfolio of combination formulations and dosage forms. Appropriate formulation proficiency and manufacturing controls are necessary to keep up an even high quality.
In the case of product line development for a franchise or marketing company, input includes manufacturing, raw material quality, formulation, packaging, documentation and supply.
Beginning with pharmaceutical- grade raw materials, quality starts when a formula is created and includes formulation, production with strict quality controls, quality testing, packaging, warehousing and distribution. Pharmaceutical manufacturers have rigorous quality-control procedures to ensure consistency between batches.
If necessary, specific data could be brought to the fore for comparison, in particular content uniformity, assay, hardness, friability, disintegration, physical appearance, stability, packaging and batch traceability.
Box of Aceclofenac 100mg + Drotaverine 80mg Tablets In general, this combined drug product comprising Aceclofenac 100mg + Drotaverine 80mg Tablets is produced by the combination of ingredients following formulation, refining, manufacturing, analytical testing, and packaging. Proper control measures should be given during each step in the production of the drug product. This will enable pharmaceutical companies to produce standardized, professional, and consistent products and establishing a trustworthy pharmaceutical product line.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech